Marching-in could allow federal government to commercialize inventions, but at the expense of patent rights.
The COVID-19 pandemic tests the strength of U.S. bans on single-use plastic products.
Federal health agencies should work together to address public health problems.
Despite ethical concerns, scholar argues that gene editing of human embryos should not be banned.
Rule would address concerns that medical information can be used for unauthorized purposes.
Court asks government to protect vulnerable people from poorly-run trials.
Rep. Sensenbrenner spotlights controversial avian flu studies.
Lawsuits over stem cell research could alter current scientific approaches.